3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
39
Leukemia, Myeloid, Acute
35
Myelodysplastic Syndromes
33
Multiple Myeloma
30
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Graft vs Host Disease
26
Leukemia, Lymphocytic, Chronic, B-Cell
25
Lymphoma
24
Leukemia
24
Hematologic Neoplasms
20
Neoplasms
18
Lymphoma, Mantle-Cell
18
Sarcoma
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Breast Neoplasms
17
Tuberous Sclerosis
15
Myeloproliferative Disorders
15
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma, Follicular
14
Burkitt Lymphoma
14
Waldenstrom Macroglobulinemia
13
Lymphoma, B-Cell, Marginal Zone
13
Recurrence
12
Neoplasm Metastasis
12
Carcinoma, Non-Small-Cell Lung
12
Prostatic Neoplasms
11
Primary Myelofibrosis
11
Melanoma
11
Leukemia, Myelomonocytic, Chronic
11
Interventions
Cisplatin
8
Carboplatin
8
X-Rays
7
Specimen Handling
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
Vincristine
5
Nuclear Medicine Department, Hospital
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Doxorubicin
5
Biopsy
5
sodium thiosulfate
4
Melphalan
4
Irinotecan
4
Fluorouracil
4
fludarabine
3
Thiotepa
3
Oxaliplatin
3
Mesna
3
Gemcitabine
3
Filgrastim
3
Busulfan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hepatoblastoma
×
Sirolimus
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled